Related Experiment Video

Updated: May 9, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death

G Wang1, J J Wang, X L Chen

  • 1Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, People's Republic of China.

Cell Death & Disease
|August 3, 2013
PubMed

Insights

Quercetin nanoliposomes (QUE-NLs) trigger C6 glioma cell death by modulating the JAK2/STAT3 and mitochondrial pathways. This research reveals QUE-NLs as a potential therapeutic strategy for chemical-resistant gliomas.

Area of Science:

  • Oncology
  • Nanotechnology
  • Molecular Biology

Background:

  • Quercetin nanoliposomes (QUE-NLs) enhance the antitumor activity of quercetin in C6 glioma cells.
  • High concentrations of QUE-NLs induce necrotic cell death in glioma cells.

Purpose of the Study:

  • To investigate the molecular mechanisms of QUE-NL-induced C6 glioma cell death.
  • To determine the involvement of the Bcl-2 family, mitochondrial pathway, and STAT3 signaling in QUE-NLs' effects.

Main Methods:

  • Analysis of Bcl-2 family protein expression (Bcl-2, Bax) in QUE-NL treated C6 glioma cells.
  • Assessment of JAK2 and STAT3 activation following QUE-NL exposure.
  • Investigation of STAT3-mediated signaling pathways influencing mRNA expression.

Main Results:

  • QUE-NLs downregulated Bcl-2 and upregulated Bax, indicating Bcl-2 family involvement in cell death.
  • JAK2 and STAT3 activation were altered by QUE-NLs.
  • QUE-NLs modulated Bcl-2 and mitochondrial mRNA expression via STAT3-mediated pathways.

Conclusions:

  • QUE-NLs induce C6 glioma cell death through modulation of the JAK2/STAT3 and ROS-mediated mitochondrial pathways.
  • Targeting JAK2/STAT3 and the mitochondrial pathway alongside QUE-NLs may enhance treatment for chemical-resistant gliomas.

More Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...